Critical Outcome Technologies Inc. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Critical Outcome Technologies Inc. with three other
companies in this sector in Canada:
Novoheart Holdings Inc
sales of 11,560.00 Canadian Dollars [US$9,277.71 ]
Abattis Bioceuticals Corp
(17,448.00 Canadian Dollars [US$14,003.24 ]
Promis Neurosciences Inc
(49,516.00 Canadian Dollars [US$39,740.06 ]
of which 100%
was Research and Development).